Often considered a silent disease, MASH frequently presents no noticeable symptoms until substantial liver damage has already occurred, making early detection through regular screenings vital to prevent further progression and complications
Whether at the office, in the gym, or on the go, the gentle patches glp-1 design fits smoothly into everyday routines
Low protein intake during GLP-1 therapy leads to excessive muscle loss relative to fat loss
Proponents suggest that certain probiotic strains may increase endogenous GLP-1 secretion by improving gut barrier function, reducing inflammation, or producing short-chain fatty acids that stimulate L-cells
Outcomes: Studies reporting incident gastrointestinal cancers (colorectal, pancreatic, gastric, liver, or biliary tract cancers), either as primary, secondary, or safety out-comes